scholarly article | Q13442814 |
P50 | author | Elliot K. Fishman | Q56523823 |
Gary Gerstenblith | Q109719930 | ||
Bruce W. Hollis | Q110282309 | ||
P2093 | author name string | John Bartlett | |
Hong Lai | |||
Hong Tai | |||
Shenghan Lai | |||
Barbara Detrick | |||
Joseph Cofrancesco | |||
Shaoguang Chen | |||
Wenjing Tong | |||
Jeffrey A Brinker | |||
Sandeepan Bhatia | |||
P2860 | cites work | Prediction of Coronary Heart Disease Using Risk Factor Categories | Q22241923 |
Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response | Q28298985 | ||
Heart disease and stroke statistics--2011 update: a report from the American Heart Association | Q29547236 | ||
Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey | Q31115409 | ||
Vitamin D-dependent suppression of endothelin-induced vascular smooth muscle cell proliferation through inhibition of CDK2 activity | Q33697824 | ||
Decreased bioavailability of vitamin D in obesity | Q33916095 | ||
A role for the cell cycle phosphatase Cdc25a in vitamin D-dependent inhibition of adult rat vascular smooth muscle cell proliferation | Q34083319 | ||
1,25-dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells | Q34264285 | ||
Heart and HAART: Two sides of the coin for HIV-associated cardiology issues | Q34390565 | ||
Vitamin D deficiency and risk of cardiovascular disease | Q34586829 | ||
Vitamin D deficiency is associated with significant coronary stenoses in asymptomatic African American chronic cocaine users | Q35056311 | ||
Coronary heart disease and lipid-modifying treatment in African American patients | Q35766786 | ||
Vitamin D and disease prevention with special reference to cardiovascular disease | Q36442700 | ||
Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease | Q36512300 | ||
Vitamin D3 supplementation for 16 weeks improves flow-mediated dilation in overweight African-American adults | Q37267789 | ||
Long-term cocaine use and antiretroviral therapy are associated with silent coronary artery disease in African Americans with HIV infection who have no cardiovascular symptoms | Q37277657 | ||
Long-term combination antiretroviral therapy is associated with the risk of coronary plaques in African Americans with HIV infection | Q37387607 | ||
The Rapidly Evolving Research on Vitamin D Among HIV-Infected Populations | Q37838799 | ||
Coronary Plaque Disruption | Q40459835 | ||
1,25-Dihydroxyvitamin D3 and rat vascular smooth muscle cell growth | Q41860456 | ||
A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness | Q42957603 | ||
Combination antiretroviral therapy and the risk of myocardial infarction | Q44662157 | ||
Human immunodeficiency virus 1 infection, cocaine, and coronary calcification | Q45489884 | ||
Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection | Q45729086 | ||
Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality | Q46523052 | ||
Effects of Vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells | Q46646123 | ||
Coronary risk prediction in adults (the Framingham Heart Study) | Q52596211 | ||
Interscan variation in coronary artery calcium quantification in a large asymptomatic patient population. | Q52919711 | ||
Diagnostic performance of coronary angiography by 64-row CT. | Q53383960 | ||
Ultraviolet B and blood pressure | Q56087784 | ||
Class of Antiretroviral Drugs and the Risk of Myocardial Infarction | Q57181081 | ||
Relation of Vitamin D Deficiency to Cardiovascular Risk Factors, Disease Status, and Incident Events in a General Healthcare Population | Q59689697 | ||
Prevalence of silent myocardial ischemia in asymptomatic individuals with subclinical atherosclerosis detected by electron beam tomography | Q80419413 | ||
Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer | Q80568407 | ||
P433 | issue | 5 | |
P921 | main subject | coronary artery disease | Q844935 |
vitamin B12 deficiency | Q3234995 | ||
vitamin D deficiency | Q4138762 | ||
vitamin D | Q175621 | ||
P304 | page(s) | 801-807 | |
P577 | publication date | 2012-06-01 | |
P1433 | published in | Journal of Investigative Medicine | Q15759787 |
P1476 | title | Vitamin D deficiency is associated with the development of subclinical coronary artery disease in African Americans with HIV infection: a preliminary study | |
P478 | volume | 60 |
Q99240023 | Alveolar Bone Loss, Tooth Loss and Oral Cancer Mortality in Older Patients: A Retrospective Cohort Study |
Q35154069 | Change in vitamin d levels occurs early after antiretroviral therapy initiation and depends on treatment regimen in resource-limited settings |
Q36381307 | Interventions to address chronic disease and HIV: strategies to promote exercise and nutrition among HIV-infected individuals. |
Q35935280 | Prevalence and risk factors of micronutrient deficiencies pre- and post-antiretroviral therapy (ART) among a diverse multicountry cohort of HIV-infected adults |
Q41976478 | Vitamin D Deficiency Accelerates Coronary Artery Disease Progression in Swine. |
Q37134748 | Vitamin D deficiency is associated with coronary artery calcification in cardiovascularly asymptomatic African Americans with HIV infection |
Q37324416 | Vitamin D deficiency is associated with development of subclinical coronary artery disease in HIV-infected African American cocaine users with low Framingham-defined cardiovascular risk |
Search more.